Insertable Heart Monitors Market Size, Share, Growth, and Industry Analysis, By Type (Implantation Loop Recorder (ILR), Insertable Cardiac Monitor (ICM)), By Application (Medical, Household), Regional Insights and Forecast to 2035

Insertable Heart Monitors Market Overview

Insertable Heart Monitors Market size is projected at USD 1424.64 million in 2026 and is expected to hit USD 2930.38 million by 2035 with a CAGR of 8.35%.

The Insertable Heart Monitors Market is experiencing substantial expansion due to the increasing prevalence of cardiac arrhythmias, unexplained syncope, atrial fibrillation, and long-term cardiovascular monitoring requirements across healthcare systems. Insertable heart monitors, also referred to as implantable cardiac monitoring devices, provide continuous electrocardiographic surveillance for extended periods, enabling clinicians to detect intermittent cardiac abnormalities that conventional monitoring systems may miss. More than 64 million individuals globally are estimated to be affected by atrial fibrillation, while cardiovascular diseases account for approximately 18 million deaths annually, creating a significant demand for advanced cardiac diagnostic technologies. Modern insertable heart monitors are characterized by miniaturized designs, wireless connectivity, automated arrhythmia detection algorithms, and remote patient management capabilities. Increasing adoption of ambulatory cardiac monitoring programs, rising healthcare expenditure on cardiovascular diagnostics, and growing emphasis on preventive cardiology are supporting market development. Healthcare providers are increasingly utilizing insertable heart monitors to improve diagnostic accuracy, reduce recurrent hospital admissions, and enhance long-term patient outcomes across both developed and emerging healthcare markets.

The United States represents one of the most advanced markets for insertable heart monitors due to the high burden of cardiovascular disorders and extensive deployment of remote monitoring technologies. More than 6 million Americans live with atrial fibrillation, and nearly 805,000 people experience a heart attack annually. Approximately 1 in 4 deaths in the country is linked to cardiovascular disease, supporting widespread demand for continuous cardiac rhythm monitoring solutions. Over 50% of cardiac diagnostic procedures in specialized electrophysiology centers involve long-term rhythm assessment technologies. More than 70% of major hospitals have integrated remote cardiac monitoring platforms into routine clinical workflows. Increasing utilization of minimally invasive monitoring devices among elderly patients, who account for nearly 17% of the national population, is further supporting device adoption. Advanced reimbursement structures, high physician awareness, and extensive use of digital health platforms continue to strengthen demand for insertable heart monitors across the U.S. healthcare ecosystem.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 58% of monitored cardiac patients require extended rhythm assessment, while approximately 42% of arrhythmia episodes remain undetected through short-duration monitoring methods, increasing demand for insertable heart monitoring technologies.
• Major Market Restraint: Nearly 34% of healthcare facilities report procedural cost concerns, while approximately 29% of eligible patients delay implantation due to concerns regarding invasive diagnostic procedures and follow-up requirements.
• Emerging Trends: Around 68% of newly introduced monitoring systems incorporate wireless connectivity, while more than 55% utilize artificial intelligence-assisted rhythm analysis and automated event classification capabilities for enhanced diagnostics.
• Regional Leadership: North America accounts for approximately 41% of global procedure volume, while Europe contributes nearly 29%, supported by extensive cardiovascular screening programs and advanced electrophysiology infrastructure.
• Competitive Landscape: The top five manufacturers collectively contribute over 72% of product installations, while nearly 48% of innovation initiatives focus on miniaturization, remote monitoring integration, and diagnostic algorithm enhancement.
• Market Segmentation: Implantable monitoring devices account for nearly 63% of clinical utilization, while hospital-based applications represent approximately 57% of total procedure demand across major healthcare institutions.
• Recent Development: More than 61% of recently launched systems feature smartphone integration, while approximately 46% include enhanced data transmission capabilities and advanced atrial fibrillation detection functionalities.

Insertable Heart Monitors Market Latest Trends

The Insertable Heart Monitors Market is witnessing significant technological transformation driven by digital healthcare integration, miniaturization, artificial intelligence, and remote patient monitoring adoption. One of the most prominent trends is the increased deployment of smartphone-compatible insertable heart monitors capable of transmitting real-time cardiac rhythm information directly to physicians and monitoring centers. More than 65% of newly commercialized devices now support wireless communication technologies, enabling continuous patient surveillance outside traditional clinical environments.

Artificial intelligence-assisted arrhythmia detection is becoming increasingly prevalent, with automated algorithms demonstrating diagnostic sensitivity improvements exceeding 30% compared with earlier-generation monitoring technologies. Nearly 60% of healthcare organizations implementing cardiac remote monitoring programs report improved patient engagement and faster arrhythmia identification. Another notable trend is device miniaturization, with modern monitors becoming more than 80% smaller than earlier implantable cardiac monitoring systems, reducing procedural complexity and improving patient comfort.

Expansion of telecardiology services is also contributing to market evolution. More than 50% of cardiology departments in advanced healthcare systems have integrated remote monitoring pathways into routine patient management. Increased emphasis on stroke prevention strategies has accelerated insertable monitor utilization for cryptogenic stroke patients, where continuous monitoring significantly improves atrial fibrillation detection rates. Enhanced cloud-based analytics, predictive diagnostics, and integrated electronic health record connectivity continue shaping the future landscape of the Insertable Heart Monitors Market.

Insertable Heart Monitors Market Dynamics

DRIVER

"Growing Burden of Cardiac Arrhythmias and Atrial Fibrillation"

The primary growth driver for the Insertable Heart Monitors Market is the rapidly increasing prevalence of cardiac rhythm disorders worldwide. Atrial fibrillation affects tens of millions of individuals globally and remains one of the leading causes of ischemic stroke, heart failure, and cardiovascular hospitalization. Studies indicate that nearly 20% to 30% of ischemic strokes occur without an immediately identifiable cause, creating a strong clinical need for long-term cardiac rhythm monitoring solutions. Insertable heart monitors enable continuous surveillance for periods exceeding traditional external monitoring capabilities, significantly increasing diagnostic yield.

More than 40% of intermittent arrhythmias remain undetected during short-duration electrocardiographic examinations. Long-term monitoring devices improve detection rates by over 50% in patients experiencing infrequent symptoms. Increasing life expectancy further contributes to demand, as cardiac rhythm abnormalities become increasingly prevalent among aging populations. Individuals aged over 65 years represent a substantial proportion of arrhythmia-related hospital admissions. Additionally, approximately 70% of electrophysiologists report increased utilization of implantable monitoring technologies for patients with unexplained syncope and cryptogenic stroke. Growing physician awareness, advancements in diagnostic algorithms, and expanding use of remote monitoring services continue strengthening market demand across hospitals, specialty cardiac centers, and ambulatory healthcare settings.

RESTRAINTS

"Procedure Costs and Limited Accessibility in Developing Regions"

Despite strong adoption trends, the Insertable Heart Monitors Market faces restraints associated with implantation costs, infrastructure limitations, and uneven reimbursement coverage. Implantation procedures require trained healthcare professionals, specialized equipment, and follow-up monitoring systems, creating accessibility challenges in several healthcare environments. Surveys indicate that nearly one-third of healthcare providers identify procedural expenditure as a significant consideration influencing technology adoption.

In many low- and middle-income countries, cardiovascular diagnostic infrastructure remains concentrated within urban healthcare centers, limiting patient access to advanced monitoring technologies. More than 45% of rural healthcare facilities lack specialized electrophysiology services required for comprehensive cardiac rhythm assessment. Furthermore, patient acceptance challenges persist, with approximately 25% to 30% of eligible individuals expressing hesitation toward minimally invasive implantation procedures.

Data management requirements also contribute to implementation complexity. Healthcare providers must maintain secure communication networks, patient monitoring platforms, and clinical review systems to effectively utilize insertable monitoring technologies. Variability in reimbursement policies across different healthcare systems creates additional adoption barriers. Smaller healthcare organizations may face budgetary constraints when implementing remote monitoring programs. These factors collectively restrict market penetration in certain regions despite increasing clinical evidence supporting long-term cardiac monitoring benefits.

OPPORTUNITY

"Expansion of Remote Patient Monitoring and Digital Cardiology"

One of the most significant opportunities within the Insertable Heart Monitors Market is the accelerating adoption of remote patient monitoring ecosystems and digital cardiology solutions. Healthcare systems increasingly prioritize continuous patient surveillance outside hospital environments to improve outcomes, reduce readmission rates, and optimize clinical resource utilization. More than 60% of healthcare institutions are actively investing in connected care technologies and remote monitoring infrastructure.

Insertable heart monitors are uniquely positioned within this transformation due to their ability to deliver uninterrupted cardiac rhythm information over extended durations. Remote monitoring platforms can reduce unnecessary outpatient visits by approximately 35% while improving arrhythmia detection efficiency. Cloud-based analytics and artificial intelligence technologies enable automated identification of clinically significant cardiac events, reducing clinician workload and improving response times.

Expansion of wearable-device ecosystems further supports integration opportunities between implantable monitoring systems and broader digital health networks. More than 50% of patients participating in remote cardiac care programs demonstrate higher treatment adherence compared with conventional monitoring approaches. Emerging healthcare markets are also increasing investment in telemedicine infrastructure, creating additional deployment opportunities. Continued innovation in wireless connectivity, battery efficiency, predictive analytics, and patient-centered digital platforms is expected to create substantial growth potential for manufacturers and healthcare providers operating within the insertable heart monitoring sector.

CHALLENGE

"Data Management Complexity and Clinical Workflow Integration"

A major challenge affecting the Insertable Heart Monitors Market involves managing large volumes of continuously generated patient data while maintaining efficient clinical workflows. Modern insertable monitoring systems can generate thousands of rhythm recordings per patient annually, requiring sophisticated analysis platforms and dedicated clinical review processes. Healthcare providers frequently encounter challenges associated with interpreting device-generated alerts, minimizing false-positive notifications, and prioritizing clinically relevant events.

Approximately 40% of cardiology departments report increased administrative workload associated with monitoring data review and patient communication activities. Integration with electronic health records remains inconsistent across healthcare systems, creating interoperability concerns and workflow inefficiencies. Data privacy regulations continue evolving globally, requiring healthcare organizations to implement secure transmission, storage, and access control mechanisms.

Additionally, shortages of specialized electrophysiology professionals may affect monitoring program scalability in certain regions. Training requirements for clinicians, technicians, and support personnel add operational complexity. As remote monitoring adoption expands, healthcare providers must balance growing data volumes with efficient clinical decision-making processes, making workflow optimization a critical challenge across the market.

Insertable Heart Monitors Market Segmentation

The Insertable Heart Monitors Market is segmented by device type and clinical application. Market demand is primarily influenced by long-term arrhythmia monitoring requirements, cryptogenic stroke assessment, syncope diagnosis, and atrial fibrillation detection. Technological advancements in miniaturization, wireless communication, and automated diagnostics support broader utilization across healthcare settings. Device selection often depends on monitoring duration, diagnostic objectives, patient characteristics, and healthcare provider preferences. Growing emphasis on preventive cardiology and remote monitoring continues driving adoption across multiple patient populations.

Download FREE Sample to learn more about this report.

BY TYPE

Implantation Loop Recorder (ILR): Implantation Loop Recorders remain a widely utilized category within long-term cardiac rhythm monitoring due to their ability to continuously record and store electrocardiographic data over extended periods. These devices are particularly valuable for patients experiencing infrequent symptoms such as unexplained syncope, palpitations, and transient arrhythmias that may not be captured through conventional monitoring approaches. Clinical studies indicate that ILRs improve arrhythmia detection rates by more than 45% compared with traditional short-duration monitoring techniques. Approximately 60% of patients undergoing prolonged diagnostic evaluation for recurrent unexplained fainting episodes benefit from ILR-based monitoring strategies. The devices support automatic event recording and patient-triggered activation mechanisms, enabling comprehensive rhythm documentation. More than 70% of electrophysiology specialists consider ILRs an effective diagnostic solution for intermittent cardiac rhythm abnormalities. Continuous improvements in device miniaturization have reduced implantation complexity by nearly 50%, enhancing procedural efficiency and patient acceptance. Wireless data transmission capabilities, remote monitoring integration, and advanced arrhythmia detection algorithms continue expanding clinical utilization. Growing prevalence of cardiovascular disorders and increasing demand for ambulatory diagnostic technologies further support adoption of Implantation Loop Recorders across hospitals and specialized cardiac care centers.

Insertable Cardiac Monitor (ICM): Insertable Cardiac Monitors represent an advanced segment of the insertable heart monitoring industry, offering extended diagnostic capabilities, sophisticated analytics, and enhanced connectivity features. These devices are increasingly utilized for long-term atrial fibrillation detection, cryptogenic stroke investigations, and ongoing cardiac rhythm surveillance among high-risk patient populations. Clinical evidence demonstrates that ICMs can increase atrial fibrillation detection by over 35% compared with conventional monitoring pathways. Approximately 55% of patients with unexplained stroke events undergo prolonged rhythm assessment utilizing insertable monitoring technologies. Modern ICM systems incorporate wireless communication modules, enabling near real-time transmission of diagnostic information to healthcare providers. More than 65% of newly deployed ICM platforms support remote monitoring ecosystems that facilitate continuous patient management outside hospital settings. Automated rhythm classification algorithms have improved diagnostic efficiency by approximately 30%, reducing manual review requirements for clinicians. Enhanced battery longevity, compact device architecture, and improved patient comfort contribute to increasing adoption. Healthcare organizations implementing remote cardiac monitoring programs report notable improvements in early arrhythmia identification and clinical intervention timelines. Rising demand for connected healthcare solutions and precision cardiovascular diagnostics continues strengthening the position of Insertable Cardiac Monitors within the broader cardiac monitoring landscape.

BY APPLICATION

Medical: The medical application segment represents the primary utilization area for insertable heart monitors due to the increasing prevalence of arrhythmias, atrial fibrillation, cryptogenic stroke, syncope, and other cardiovascular rhythm disorders. More than 85% of implant procedures are performed within hospitals, specialty cardiac centers, electrophysiology clinics, and ambulatory healthcare facilities. Clinical studies indicate that continuous insertable monitoring improves arrhythmia detection rates by approximately 52% compared with traditional short-term Holter monitoring systems. Nearly 38% of patients with unexplained syncope experience clinically significant rhythm abnormalities identified through long-term implantable monitoring. Around 47% of cryptogenic stroke patients monitored for extended durations demonstrate previously undiagnosed atrial fibrillation episodes. More than 72% of electrophysiologists prefer insertable monitoring devices for patients experiencing infrequent cardiac symptoms. Remote monitoring integration has enabled approximately 63% faster transmission of clinically relevant rhythm events to physicians. Furthermore, over 58% of cardiovascular diagnostic departments utilize automated arrhythmia detection algorithms integrated into insertable heart monitors. Approximately 69% of monitored patients report improved diagnostic confidence due to continuous surveillance capabilities. The growing elderly population, accounting for nearly 17% of global demographics in several developed economies, further strengthens medical demand for insertable cardiac monitoring technologies, supporting their widespread deployment across advanced cardiovascular care pathways.

Household: The household application segment is expanding steadily as remote patient monitoring, telehealth infrastructure, and connected healthcare ecosystems become increasingly integrated into routine cardiovascular management. More than 61% of patients using insertable heart monitors participate in home-based monitoring programs supported by digital communication platforms. Approximately 54% of healthcare providers report improved patient compliance when monitoring data can be transmitted directly from home environments without requiring frequent clinical visits. Wireless-enabled insertable monitoring systems now account for nearly 68% of active household-based cardiac surveillance programs. Studies demonstrate that home-monitored cardiac patients experience approximately 34% fewer unnecessary outpatient consultations due to real-time physician access to diagnostic information. Around 49% of elderly cardiac patients prefer home-based monitoring solutions because they reduce travel requirements and improve convenience. More than 57% of remote cardiac care programs utilize smartphone-connected monitoring platforms for symptom reporting and device communication. Automated alert systems identify approximately 42% of clinically significant rhythm abnormalities within the first weeks of monitoring, supporting earlier intervention. Household utilization is particularly valuable for individuals with intermittent arrhythmias, where nearly 46% of abnormal rhythm events occur outside conventional healthcare settings. Growing awareness of preventive cardiology, digital health adoption exceeding 60% in several developed regions, and increasing acceptance of telemedicine continue expanding household applications for insertable heart monitoring technologies.

Insertable Heart Monitors Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America remains the leading regional market for insertable heart monitors due to advanced cardiovascular care infrastructure, widespread adoption of remote patient monitoring technologies, and a high prevalence of cardiac rhythm disorders. More than 41% of global insertable monitoring procedures are performed across North American healthcare facilities. Approximately 6 million individuals experience atrial fibrillation within the region, while nearly 25% of cardiovascular-related hospitalizations involve rhythm monitoring assessments. Over 73% of tertiary-care hospitals have integrated remote cardiac monitoring systems into standard clinical workflows. Around 66% of newly implanted devices feature wireless data transmission capabilities linked directly to physician monitoring platforms. More than 59% of electrophysiology specialists utilize insertable monitoring technologies for unexplained syncope investigations. The elderly population represents approximately 18% of regional demographics, supporting long-term monitoring demand. Nearly 62% of cardiac diagnostic centers employ artificial intelligence-assisted rhythm interpretation software. Continuous investments in digital healthcare infrastructure and strong physician awareness contribute to increasing utilization rates. More than 53% of monitored patients benefit from automated event notifications, improving diagnostic efficiency and accelerating treatment decisions throughout the region.

Europe

Europe represents a significant market for insertable heart monitors, supported by extensive cardiovascular screening initiatives, increasing arrhythmia prevalence, and advanced public healthcare systems. Approximately 29% of global implantable cardiac monitoring procedures occur across European healthcare institutions. More than 11 million individuals in the region are estimated to experience atrial fibrillation, creating substantial demand for continuous rhythm assessment solutions. Around 67% of specialized cardiac centers offer remote monitoring services integrated with insertable monitoring technologies. Nearly 58% of implant recipients are aged above 65 years, reflecting the influence of an aging population on diagnostic demand. More than 51% of electrophysiologists report increasing utilization of insertable monitors for cryptogenic stroke investigations. Approximately 63% of healthcare facilities utilize cloud-based monitoring platforms for secure patient data management. Device miniaturization advancements have reduced implantation procedure times by nearly 35%, improving patient acceptance. Around 56% of hospitals employ automated arrhythmia classification systems to support clinical decision-making. Government-supported digital health initiatives and growing awareness of preventive cardiovascular care continue strengthening market expansion across major European healthcare systems.

Asia-Pacific

Asia-Pacific is emerging as one of the fastest-developing markets for insertable heart monitors due to rapid healthcare modernization, growing cardiovascular disease prevalence, and expanding access to advanced diagnostic technologies. More than 35% of the global population resides within countries experiencing significant increases in age-related cardiovascular disorders. Approximately 45% of major urban hospitals have implemented remote cardiac monitoring programs utilizing implantable monitoring solutions. Nearly 52% of healthcare investments targeting cardiovascular diagnostics involve digital monitoring technologies and telemedicine infrastructure. The prevalence of atrial fibrillation and related rhythm disorders continues increasing, with more than 20 million individuals estimated to be affected across the region. Around 48% of tertiary cardiac centers now perform routine insertable monitor implantation procedures for long-term arrhythmia detection. Wireless-enabled monitoring devices account for approximately 61% of new installations. More than 44% of clinicians report improved patient outcomes through continuous monitoring strategies compared with conventional diagnostic approaches. Expanding insurance coverage, increased physician training, and growing awareness regarding early cardiovascular diagnosis continue supporting broader adoption. The region is also witnessing increasing integration of artificial intelligence technologies, utilized by nearly 39% of advanced monitoring programs.

Middle East & Africa

The Middle East & Africa market for insertable heart monitors is developing steadily due to rising cardiovascular disease incidence, increasing healthcare investments, and expanding access to specialized cardiology services. Approximately 31% of adults in several regional markets present one or more cardiovascular risk factors, creating demand for advanced diagnostic monitoring technologies. Around 43% of tertiary healthcare institutions now provide implantable cardiac monitoring procedures as part of comprehensive arrhythmia management programs. Nearly 37% of cardiac diagnostic facilities have implemented remote monitoring platforms connected to wireless implantable devices. More than 46% of healthcare providers report increasing referrals for long-term rhythm assessment among patients with unexplained syncope and stroke-related conditions. Approximately 54% of newly established cardiovascular centers incorporate digital patient monitoring systems within routine clinical operations. Urban healthcare facilities account for nearly 68% of implant procedures due to stronger infrastructure availability. Device awareness among physicians has improved significantly, with approximately 49% of cardiologists recommending prolonged monitoring for intermittent rhythm abnormalities. Increasing healthcare modernization initiatives, growing adoption of telemedicine technologies, and enhanced specialist training programs continue creating favorable conditions for insertable heart monitor deployment across the Middle East and Africa region.

List of Key Insertable Heart Monitors Market Companies

• Medtronic
• Abbott
• Boston Scientific Corporation
• BIOTRONIK
• Vectorious
• LivaNova
• Phoenix Heart
• Angel Medical Systems

Top Companies with Highest Market Share

• Medtronic: Accounts for approximately 38% of global insertable heart monitor installations, supported by extensive physician adoption, broad geographic presence, and advanced remote monitoring capabilities. More than 70% of major electrophysiology centers maintain active utilization of the company’s insertable monitoring platforms for arrhythmia detection and long-term cardiac surveillance.
• Abbott: Represents nearly 27% of global deployment volume within the insertable heart monitor segment. Approximately 65% of users benefit from smartphone-enabled monitoring functionality, while over 55% of implanting specialists utilize its remote diagnostic ecosystem for continuous rhythm assessment and rapid clinical event identification.

Investment Analysis and Opportunities

The Insertable Heart Monitors Market continues attracting investment due to increasing demand for continuous cardiac monitoring, digital healthcare integration, and advanced arrhythmia detection technologies. More than 62% of investment activity within cardiovascular diagnostics is directed toward connected monitoring platforms, artificial intelligence applications, and remote patient management solutions. Approximately 57% of healthcare organizations plan to expand digital cardiac monitoring capabilities, creating favorable conditions for technology providers and device manufacturers.

Investors are increasingly focusing on miniaturized implantable devices, with nearly 48% of development initiatives targeting reductions in device size and procedural complexity. Around 54% of healthcare providers prioritize wireless communication functionality when selecting monitoring technologies, creating opportunities for advanced connectivity solutions. Artificial intelligence-based arrhythmia detection systems have demonstrated efficiency improvements exceeding 30%, encouraging further capital allocation toward predictive analytics platforms. Emerging healthcare markets also provide significant opportunities, as more than 45% of hospitals are expanding cardiovascular diagnostic capabilities. Telemedicine adoption rates exceeding 60% in several regions further support investment potential. Growing demand for home-based cardiac monitoring, improved patient compliance levels approaching 69%, and increasing deployment of cloud-based healthcare platforms continue generating attractive opportunities across the insertable heart monitoring value chain.

New Products Development

Product development within the Insertable Heart Monitors Market is increasingly focused on miniaturization, artificial intelligence integration, enhanced battery performance, and seamless remote monitoring connectivity. More than 61% of newly introduced monitoring devices support direct wireless communication with mobile applications and physician monitoring portals. Approximately 52% of recent innovations incorporate automated arrhythmia classification algorithms designed to reduce manual interpretation workloads.

Manufacturers are emphasizing patient comfort through device size reductions exceeding 40% compared with earlier implantable monitoring platforms. Nearly 58% of newly developed systems provide improved sensing accuracy and expanded memory capacity for long-term rhythm recording. Enhanced battery technologies now extend operational lifespans by more than 35%, reducing replacement requirements and improving clinical efficiency. Around 46% of new-generation devices feature advanced atrial fibrillation detection capabilities supported by machine-learning analytics. Integration with cloud-based healthcare platforms has increased by approximately 55%, enabling secure data sharing and remote physician access. Product developers are also prioritizing cybersecurity enhancements, with more than 43% of innovations incorporating advanced data protection mechanisms. These developments continue improving diagnostic performance, patient engagement, and healthcare provider productivity across global cardiac monitoring programs.

Five Recent Developments (2023-2025)

• Advanced AI-Based Arrhythmia Detection Integration: Multiple industry participants expanded artificial intelligence capabilities within insertable monitoring systems. New algorithms improved arrhythmia classification ac

  Insertable Heart Monitors Market Report Coverage

  REPORT COVERAGE	DETAILS
  Market Size Value In	USD 1424.64 Million in 2026
  Market Size Value By	USD 2930.38 Million by 2035
  Growth Rate	CAGR of 8.35% from 2026 - 2035
  Forecast Period	2026 - 2035
  Base Year	2025
  Historical Data Available	Yes
  Regional Scope	Global
  Segments Covered
  	By Type Implantation Loop Recorder (ILR) Insertable Cardiac Monitor (ICM)
  	By Application Medical Household